Clinical Trials on Anxious Disorder in Japan
Total 2208 results
-
Otsuka Pharmaceutical Co., Ltd.CompletedMajor Depressive DisorderJapan
-
Osaka City UniversityCompletedSSRI-Refractory Obsessive-Compulsive DisorderJapan
-
Mochida Pharmaceutical Company, Ltd.PfizerCompleted
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Astellas Pharma IncCompleted
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Astellas Pharma IncCompleted
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruiting
-
GlaxoSmithKlineCompleted
-
National Center of Neurology and Psychiatry, JapanCompletedAnxiety Disorders | Depressive DisordersJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Nagoya City UniversityUnknownPervasive Developmental DisorderJapan
-
Showa UniversityCompletedMajor Depressive DisorderJapan
-
GlaxoSmithKlineCompletedDepressive DisorderJapan
-
Nagoya City UniversityCompletedMajor Depressive DisorderJapan
-
Hamamatsu UniversityJapan Agency for Medical Research and DevelopmentUnknown
-
ShionogiEli Lilly and CompanyTerminated
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Komazawa UniversityCompletedCompassion | Social Anxiety DisorderJapan
-
Astellas Pharma IncCompletedMajor Depressive DisorderJapan
-
Japan Science and Technology AgencyUniversity of Toyama; Chiba UniversityCompletedTrauma | Posttraumatic Stress DisorderJapan
-
Japan Science and Technology AgencyUniversity of Toyama; Chiba UniversityCompletedTrauma | Posttraumatic Stress DisorderJapan
-
ShionogiEli Lilly and CompanyCompletedDepressive DisorderJapan
-
Nagoya City UniversityKochi UniversityCompletedMajor Depressive DisorderJapan
-
Eli Lilly and CompanyCompleted
-
GlaxoSmithKlineTerminatedStress Disorders, Post-Traumatic | Post-Traumatic Stress DisorderJapan
-
Institute for Health Economics and Policy, JapanSenzoku Stress Coping Support OfficeRecruiting
-
Novo Nordisk A/SCompletedObservational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII DeficiencyCongenital Bleeding Disorder | Congenital FVII DeficiencyJapan
-
National Center of Neurology and Psychiatry, JapanCompletedDepressive Disorder | Anxiety DisordersJapan
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding DisorderJapan
-
Taisho Pharmaceutical Co., Ltd.Completed
-
Tadashi HasegawaCompleted
-
Chiba UniversityCompletedPosttraumatic Stress DisordersJapan
-
Gunma UniversityCompletedSubthreshold DepressionJapan
-
Kibi International UniversityCompleted
-
Kyoto UniversityNagoya City UniversityCompleted
-
Novo Nordisk A/SCompletedHealthy | Acquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary BypassJapan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Glanzmann's DiseaseJapan
-
Kibi International UniversityCompletedSubthreshold DepressionJapan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsJapan
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageJapan
-
Chiba UniversityCompletedAdolescent | DepressionJapan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsJapan
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)Japan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsJapan
-
Chiba UniversityCompletedAttention Deficit Disorder With HyperactivityJapan
-
Chiba UniversityCompletedAttention Deficit and Disruptive Behavior Disorders | Hyperkinesis | Attention Deficit Disorder With Hyperactivity DiseaseJapan